Palvella Therapeutics (PVLA) Change in Acquisitions & Divestments (2018 - 2024)

Palvella Therapeutics (PVLA) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $9.0 million in Q1 2024.

• Change in Acquisitions & Divestments for Q1 2024 came in at $9.0 million, down 33.31% year-over-year; the trailing twelve-month figure through Sep 2024 was $20.0 million (down 34.01% YoY), and the FY2023 annual result was $35.0 million, up 24.14% from the prior year.
• Change in Acquisitions & Divestments fell to $9.0 million in Q1 2024 per PVLA's latest filing, from $11.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $28.4 million in Q1 2020 and troughed at $4.8 million in Q2 2022.
• A 4-year average of $13.0 million and a median of $12.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2020 and 2023: Change in Acquisitions & Divestments soared 910.91% in 2020, then plunged 70.02% in 2023.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $15.8 million in 2020, then sank by 60.0% to $6.3 million in 2022, then jumped by 74.62% to $11.0 million in 2023, then slipped by 18.19% to $9.0 million in 2024.
• Business Quant data shows PVLA's Change in Acquisitions & Divestments at $9.0 million in Q1 2024, $11.0 million in Q4 2023, and $5.1 million in Q3 2023.